ASPO Abstracts
Ability to Eat among Cancer Patients Treated for Malignant Bowel Obstruction: A Secondary Analysis within SWOG S1316
Category: Survivorship & Health Outcomes/Comparative Effectiveness Research
Conference Year: 2023
Abstract Body:
Background. Malignant bowel obstruction (MBO) elicits gastrointestinal symptoms that interfere with dietary intake. The purpose of this research was to collect dietary intake data from patients with MBO who were participating in SWOG S1316 to characterize ability to sustain oral intake during and after treatment for MBO. Methods. 199 patients diagnosed with MBO, age 23 to 91 y, were consented to report route for eating/feeding and to complete repeat, telephone-based 24- hour dietary recalls at baseline (during hospitalization), and at weeks 5, 9, and 13. Patients were categorized as: 1) consuming only liquids, 2) consuming only oral supplements (Boost, Ensure), 3) eating solids, but mostly liquids, 4) eating liquids, but mostly solids, 5) on tube feeding with small amounts of oral intake, 6) on tube feeding only, 7) no intake (ice, sips of water). Number of days alive and out of the hospital through 13 weeks defined "good days
Keywords: Malignant bowel obstruction; dietary intake